Differentiation-Dependent Expression of the BCL-2 Proto-Oncogene in the Human Trophoblast Lineage
Authors:
- 1 April 1994
- journal article
- other
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 1 (2) , 164-172
Abstract
OBJECTIVE : We explored the role of the BCL-2 proto-oncogene in the life cycle of trophoblast cells by examining: 1) the patterns of BCL-2 expression in normal placenta at various gestational ages and in specimens of hydatidiform moles and choriocarcinomas, and 2) the effects of cyclic adenosine monophosphate (cAMP) treatment of JEG-3 choriocarcinoma cells, which induces differentiated functions, on BCL-2. METHODS:BCL-2 protein was localized by indirect immunofluorescence and immunoperox idase staining of tissue sections and cells using monoclonal and polyclonal antibodies. Western and Northern blotting were used to assess BCL-2 and p53 protein and mRNA levels, respectively. JEG-3 cells were transfected with a BCL-2 expression plasmid to establish that BCL-2 protein could be expressed at high levels in this cell type. RESULTS:BCL-2 immunostaining was most prominent in the syncytiotrophoblast of normal placenta. It was found in syncytiotrophoblast of complete and partial hydatidiform moles, whereas cytotrophoblast staining was weak. BCL-2 immunostaining was also barely detectable in chorio carcinoma cells (JEG-3 cells) and a primary choriocarcinoma. However, BCL-2 protein could be transiently overexpressed in JEG-3 cells by transfection with an expression plasmid. Western blot analysis revealed low levels of BCL-2 in JEG-3 cells and a rise in BCL-2 protein in placental extracts from 10 weeks' gestation to term. In contrast, p53 protein was abundant in JEG-3 cells and normal placenta at 10 weeks'gestation, but low at term. BCL-2 transcripts were substantially more abundant in term placenta than in JEG-3 cells. Treatment of JEG-3 cells with 8-Br-cAMP, which induces genes characteristic of the syncytiotrophoblast, raised BCL-2 protein approximately twofold, whereas p53 mRNA declined. CONCLUSIONS: We conclude that: 1) There is a differentiation-dependent pattern of BCL-2 expression in the placenta, with the protein being most abundant in terminally differentiated trophoblast cells; 2) there appears to be an inverse relation between BCL-2 and p53 expression in trophoblast; and 3) cAMP regulates BCL-2 protein in trophoblast cells. We speculate that the expression of BCL-2 in terminally differentiated trophoblast cells, and hence resistance to apoptotic cell death, may be one mechanism by which trophoblast mass is preserved during pregnancy. Conversely, the relatively low expression of BCL-2 in choriocarcinoma cells may render them more susceptible to apoptosis. (J Soc Gynecol Invest 1994;1:164-72)Keywords
This publication has 19 references indexed in Scilit:
- Prevention of Programmed Cell Death in Caenorhabditis elegans by Human bcl-2Science, 1992
- Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-OncogeneScience, 1992
- Apoptotic cell death induced by c-myc is inhibited by bcl-2Nature, 1992
- The cAMP signalling system and human trophoblast functionPlacenta, 1992
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences, 1991
- Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts*1Experimental Cell Research, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- A cDNA Encoding a Rat Mitochondrial Cytochrome P450 Catalyzing Both the 26-Hydroxylation of Cholesterol and 25-Hydroxylation of Vitamin D 3 : Gonadotropic Regulation of the Cognate mRNA in OvariesDNA and Cell Biology, 1990
- Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.Proceedings of the National Academy of Sciences, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976